The Pharmaceutical Journal
Vol 273 No 7316 p340
11 September 2004

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Liraglutide trial results positive

New data have shown that liraglutide, a long-acting analogue of GLP-1 hormone currently under investigation by Novo Nordisk for type 2 diabetes, can provide improved blood glucose control without associated weight gain. The data were reported at the European Association for the Study of Diabetes in Munich this week.